#NeurodevelopmentalDisorders
📢 Special Issue on Brain Development and Neurodevelopmental Disorders
📒 Journal: Journal of Brain and Spine
📅 Final Manuscript Submission Deadline: 31/12/2026
💡 Guest editor: Da Mi, Tsinghua University, China.
🔗 Submit now:
https://ow.ly/U5xB5102kqp
#Brain #Spine #NeurodevelopmentalDisorders
November 6, 2026 at 7:30 AM
Families of children with #TuberousSclerosis complex often discontinued a #telehealth behavioural intervention because of medical crises and caregiving demands, highlighting the need for more flexible #FamilyCentredCare #NeurodevelopmentalDisorders
onlinelibrary.wiley.com/doi/10.1111/...
November 2, 2026 at 10:02 AM
“Five years ago, we were having meltdowns, bad behaviour very, very regularly. Now it virtually never happens, which is just the most fantastic progress.”

👉 Watch the full video on ACAMH Learn
#ChildMentalHealth #ASD #NeurodevelopmentalDisorders
Living with Autism, Dan and Charlie 5 years on | ACAMH Learn
Five years after their first film, Dan and Charlie return to share an honest update on Charlie’s autism journey, reflecting on the progress they've made. Through lived experience, they highlight the value of…
acamhlearn.org
October 29, 2026 at 8:31 AM
Did These Four Precision Peptides Just Erase Severe Autism Deficits?

Source: pmc.ncbi.nlm.nih.gov/articles/PMC...

Tracking prefrontal synapse repair and vocal restoration in research models.

#autismtreatment #neurodevelopmentaldisorders #synapticrepair #brainrestoration #nonverbalautism
October 17, 2026 at 7:02 PM
JMIR Formative Res: Reliability of Childhood Autism Rating Scale, Second Edition, Assessments Using Telepsychiatry for Children With Neurodevelopmental Disorders and Their Caregivers: Randomized #feasibility Study #AutismResearch #Telehealth #Telepsychiatry #CARS2 #NeurodevelopmentalDisorders
Reliability of Childhood Autism Rating Scale, Second Edition, Assessments Using Telepsychiatry for Children With Neurodevelopmental Disorders and Their Caregivers: Randomized #feasibility Study
Background: The #covid19 pandemic has increased the demand for telepsychiatry in neurodevelopmental assessment; however, few studies have examined the interrater reliability of clinician-rated autism scales, such as the Childhood Autism Rating Scale, Second Edition (CARS2), when used remotely. Although the #feasibility and validity of telehealth assessments have been explored previously, the consistency between remote and in person CARS2 ratings by different clinicians remains underinvestigated. Objective: The objective of this study was to evaluate agreement between CARS2 total scores obtained by different evaluators using telepsychiatry and face-to-face assessments in children with autism spectrum disorder (ASD) and/or attention-deficit/hyperactivity disorder (ADHD). Methods: In this randomized #feasibility study, 75 children aged 6 to 17 years with diagnoses of ASD, ADHD, or both were enrolled at 5 medical institutions in Japan; 73 of 75 were included in the final analysis. Each participant underwent 2 independent CARS2 evaluations, one face-to-face and the other via telepsychiatry, conducted by different evaluators who were blinded to each other’s ratings. Remote assessments were conducted using a secure video platform with caregiver facilitation. Agreement was assessed using intraclass correlation coefficients (ICCs) for the overall sample and subgroups defined by primary diagnosis, sex, and age. Results: The overall ICC for CARS2 total scores between face-to-face and telepsychiatry assessments was 0.582 (95% CI 0.407‐0.717), indicating moderate agreement. The ICC was 0.546 among participants with ASD as the primary diagnosis and 0.495 among those with ADHD as the primary diagnosis. Point estimates were higher among girls than boys (0.666 vs 0.495) and among children aged 11 years or older than among those aged 10 years or younger (0.676 vs 0.419). In a sensitivity analysis including all participants with an ASD diagnosis, the ICC was 0.580. Conclusions: CARS2 total scores obtained through telepsychiatry showed moderate agreement with scores obtained through face-to-face assessment when the assessments were conducted by different evaluators in different settings. Higher point estimates were observed among older children and girls, although these subgroup findings should be interpreted cautiously. Telepsychiatry-based CARS2 assessment may be considered a complementary approach rather than a replacement for comprehensive face-to-face evaluation. Larger studies using more standardized assessment protocols are needed.
dlvr.it
October 6, 2026 at 7:05 PM
October 3, 2026 at 5:20 AM
September 10, 2026 at 5:54 PM
JMIR Formative Res: An Evidence-Based AI Virtual Assistant for Young People With Attention Deficit Hyperactivity Disorder: Co-Design and Prototype Development #ADHD #MentalHealth #AI #VirtualAssistant #NeurodevelopmentalDisorders
An Evidence-Based AI Virtual Assistant for Young People With Attention Deficit Hyperactivity Disorder: Co-Design and Prototype Development
Background: Though attention deficit hyperactivity disorder (ADHD) is thought to be the most prevalent neurodevelopmental disorder in young people worldwide, there are inequalities in access to psychoeducation and health care support. One way to improve access, potentially increase engagement, reduce health care inequalities, and enhance care is by co-developing digital responsive interventions. These have the potential to support long-term condition management and to act as an adjunct to usual care. Virtual assistants that use large language models can provide information in response to questions and learn to tailor communication to suit an individual user’s needs. This can be especially valuable for people with ADHD who often struggle to regulate attention and can experience communication challenges. Involving people with lived experience in the co-design process is crucial for the development of effective digital interventions. Therefore, this article explores the views and preferences of young people with ADHD and their supporters from the United Kingdom who collaborated with researchers to co-design a prototype chatbot. Objective: This study aimed to co-develop an evidence-based chatbot prototype, intended to help young people with ADHD thrive through improved access to health care information, psychoeducation, and self-management strategies. Methods: An interdisciplinary team was established, including researchers, software developers, clinicians, and lived experience collaborators. Research advisory and working groups were set up in ways that facilitated flexible involvement. Following the person-based approach, guiding principles were established, and workshops were held with young people with ADHD and supporters of young people with ADHD to co-develop an early prototype. Feedback was sought via think-aloud interviews with lived experience collaborators. Results: In total, 9 experts by lived experience and 3 health care professionals chose to engage in workshops, and this feedback informed the development of a SmartADHD chatbot prototype. An off-the-shelf chatbot (GPT-4o hosted on Convai) was trained using resources from the National Health Service (NHS). Overall, 6 experts by lived experience engaged with think-aloud interviews, providing feedback on the prototype conversational flow and feel, the avatar, the text-to-speech, the chatbox feature, and the content of the messages. Seven recommendations are made for future development, which will inform the SmartADHD program of work. Conclusions: These findings provide rich data on the preferences of people with ADHD. Specific recommendations for a chatbot for young adults with ADHD have not been investigated before with young people, making this study a novel contribution to the field. These findings provide an excellent foundation for chatbot development for this group and may be relevant for those developing digital tools for people with ADHD across the lifespan and other neurodevelopmental conditions. Further work is required to elucidate the views of health care professionals and identify the limits of the technology before subsequent evaluation. Trial Registration:
dlvr.it
September 10, 2026 at 7:39 PM
“here, we see a diagnosis as some sort of superpower because it shows you who you really are and the things that you're brilliant at and the things that you struggle with.”

👉 Watch the full video on ACAMH Learn
#ChildMentalHealth #ASD #NeurodevelopmentalDisorders
Life as a SENCO | ACAMH Learn
This 13-minute film features SENCO Rachel discussing how parents, teachers, and health visitors can identify early developmental concerns. She explains the support schools can provide, including interventions…
acamhlearn.org
September 7, 2026 at 11:15 AM
📢 EIF1AX: A novel gene for syndromic #NeurodevelopmentalDisorders 🧬

De novo hemizygous variants in EIF1AX have been identified in males with neurodevelopmental disorders, brain abnormalities and distinctive clinical features.

🔗 Read more: www.nature.com/articles/s41...
#RareDisease #HumanGenetics
Hemizygous loss-of-function variants of EIF1AX are associated with a syndromic neurodevelopmental disorder - European Journal of Human Genetics
European Journal of Human Genetics - Hemizygous loss-of-function variants of EIF1AX are associated with a syndromic neurodevelopmental disorder
www.nature.com
August 26, 2026 at 12:24 PM
Molecular Medicine August article: Maternal immune activation disrupts the kynurenine pathway of tryptophan metabolism in the placenta–fetal brain axis in rats | #MolecularMedicine #NeurodevelopmentalDisorders #MaternalImmuneActivation #https://link.springer.com/article/10.1186/s10020-026-01587-1
August 17, 2026 at 3:00 PM
Happy to be here. My profile collage is the collage I produced for my #PhD to represent my #mothering experience disrupted by cultural narratives of #mothering, #autism, #disability #neurodevelopmentaldisorders #unpaidcarers #truecolours #love #dyscluded
November 17, 2024 at 9:46 AM
Happy to be here. My profile collage is the collage I produced for my #PhD to represent #mothering experience disrupted by cultural narratives of #mothering, #autism, #disability #neurodevelopmentaldisorders #unpaidcarers #truecolours #love #dyscluded
November 17, 2024 at 8:23 AM
January 22, 2025 at 5:01 PM
Neuroplastin is stepping into the spotlight‼️ 🧠
​A new paper highlights its crucial role in #neurodevelopmentaldisorders and #autism. Having spent my PhD studying this specific molecule, it’s amazing to see its clinical relevance expand 👏

share.google/FxTz4sIchBsw...
De novo variants in NPTN cause a neurodevelopmental disorder with autism and neuroplastin-PMCA hypofunction - Genome Medicine
Background NPTN encodes human neuroplastin (hNp), a transmembrane immunoglobulin (Ig)-superfamily glycoprotein and a subunit of the plasma membrane calcium (Ca2+)-ATPases (PMCA). The critical importance of hNp and its associations with PMCA in the human brain remains unknown. Methods Here, we describe de novo NPTN variants in individuals with autism and mild-to-severe DD/ID and evaluate their effects using animal models and in silico, molecular, and cellular approaches. Results Four individuals present variants affecting the two hNp isoforms, hNp55 and hNp65. Other four variants affect only the hNp65 isoform. Two individuals independently carry the same loss-of-function nonsense variant, predicted to cause haploinsufficient production of all hNp isoforms. Haploinsufficient Nptn+/– mice displayed reduced levels of Np and PMCA and exhibited altered social behavior. Insufficient Np55/65 production in neurons resulted in reduced PMCA expression and function. Two missense variants caused particular structural and thermodynamic abnormalities and lower expression of hNps in human embryonic kidney (HEK) cells. In primary neurons, these hNp variants failed to regulate cytosolic Ca2⁺ transients. In Drosophila, a missense mutation affecting the PMCA interaction failed to prevent the lethal phenotype caused by hNp ortholog elimination. Conclusions We show that a novel neurodevelopmental disorder characterized by intellectual disability and autism originates from haploinsufficient NPTN gene dosage or insufficient functionality of mutant hNp related to PMCA hypofunction.
share.google
July 1, 2026 at 12:25 PM
#Medsky🧪 #IDsky #pedsky #obsky #episky #Neurosky #publichealth @brainbehavimm.bsky.social Epidemiological research indicates an association between maternal exposure to influenza A virus (IAV) during pregnancy & an elevated risk of #neurodevelopmentaldisorders (NDDs) in offspring,
September 15, 2025 at 11:31 PM